Department of History of Science and Scientific Archaeology, University of Science and Technology of China, Hefei 230026, China.
Key Laboratory of Medical Molecular Virology of MOE/MOH, School of Basic Medical Sciences and Shanghai Public Health Clinical Center, Fudan University, Shanghai 200032, China.
Viruses. 2024 Feb 28;16(3):374. doi: 10.3390/v16030374.
The history of virology, which is marked by transformative breakthroughs, spans microbiology, biochemistry, genetics, and molecular biology. From the development of Jenner's smallpox vaccine in 1796 to 20th-century innovations such as ultrafiltration and electron microscopy, the field of virology has undergone significant development. In 1898, Beijerinck laid the conceptual foundation for virology, marking a pivotal moment in the evolution of the discipline. Advancements in influenza A virus research in 1933 by Richard Shope furthered our understanding of respiratory pathogens. Additionally, in 1935, Stanley's determination of viruses as solid particles provided substantial progress in the field of virology. Key milestones include elucidation of reverse transcriptase by Baltimore and Temin in 1970, late 20th-century revelations linking viruses and cancer, and the discovery of HIV by Sinoussi, Montagnier, and Gallo in 1983, which has since shaped AIDS research. In the 21st century, breakthroughs such as gene technology, mRNA vaccines, and phage display tools were achieved in virology, demonstrating its potential for integration with molecular biology. The achievements of COVID-19 vaccines highlight the adaptability of virology to global health.
病毒学的历史跨越了微生物学、生物化学、遗传学和分子生物学等多个领域,充满了变革性的突破。从詹纳(Jenner) 1796 年开发的天花疫苗,到 20 世纪的超滤和电子显微镜等创新,病毒学领域取得了重大发展。1898 年,贝杰林克(Beijerinck)为病毒学奠定了概念基础,标志着该学科发展的关键时刻。1933 年,理查德·肖普(Richard Shope)在甲型流感病毒研究方面的进展进一步加深了我们对呼吸道病原体的理解。此外,1935 年,斯坦利(Stanley)确定病毒为固体颗粒,为病毒学领域带来了重大进展。其中的关键里程碑包括 1970 年巴尔的摩(Baltimore)和泰明(Temin)阐明逆转录酶、20 世纪后期揭示病毒与癌症的关联,以及 1983 年西诺西(Sinoussi)、蒙塔尼(Montagnier)和加利(Gallo)发现 HIV,此后艾滋病研究也因此受到影响。在 21 世纪,病毒学领域在基因技术、mRNA 疫苗和噬菌体展示工具等方面取得了突破,展示了其与分子生物学融合的潜力。COVID-19 疫苗的成就突显了病毒学对全球健康的适应性。